Esco Aster Signs cGMP Exosome Manufacturing Deal with Shine-On Biomedical
Esco Aster has entered into a clinical cGMP manufacturing agreement with Shine-On Biomedical to support the production of a first-in-class HLA-G–targeting exosome drug delivery platform, while also providing technical services for exploratory exosome loading feasibility studies to advance the programme’s development.
Formulation Development | 07/01/2026 | By News Bureau | 103
Sai Life Sciences Set to Double Process R&D Capacity with New Facility in Hyderabad
The upcoming Process R&D Block at Sai Life Sciences will cover 100,000 sq. ft. across five floors, featuring 140 process chemistry fume hoods, an integrated satellite analytical lab, and dedicated peptide and oligo labs, supported by a 25,000 sq. ft. central analytical facility.
Formulation Development | 28/10/2025 | By Dineshwori | 250
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy